Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections

IF 4.7 4区 医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Katharina Skoll Mag., Julia Palmetzhofer Mag., Maria Lummerstorfer Mag., Maria Anzengruber Mag., Franz Gabor ao. Univ.-Prof. Mag. Dr., Michael Wirth ao. Univ.-Prof. Mag. Dr.
{"title":"Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections","authors":"Katharina Skoll Mag.,&nbsp;Julia Palmetzhofer Mag.,&nbsp;Maria Lummerstorfer Mag.,&nbsp;Maria Anzengruber Mag.,&nbsp;Franz Gabor ao. Univ.-Prof. Mag. Dr.,&nbsp;Michael Wirth ao. Univ.-Prof. Mag. Dr.","doi":"10.1016/j.nano.2023.102685","DOIUrl":null,"url":null,"abstract":"<div><p>Urinary tract infections (UTIs) are among the most common bacterial infections. Despite a wide range of therapeutic options, treatment success is compromised by the efficient mechanism of tissue colonization of uropathogenic <em>Escherichia coli</em>. In advanced drug delivery systems, a similar, glycan-mediated targeting mechanism may be realized by conjugating the drug to a plant lectin, like wheat germ agglutinin (WGA).</p><p>We introduce a drug delivery vehicle consisting of human serum albumin as nanoparticle shell, olive oil as core component, the active pharmaceutical ingredients (API) trimethoprim and rifampicin as well as WGA to facilitate cellular internalization. When WGA was embedded into the proteinaceous particle shell, cell binding studies revealed up to 60 % higher cell binding potential. Additionally, nanoparticles showed a good efficacy against gram-negative just as against gram-positive bacteria.</p><p>The combination of the promising cell-associative properties and the proven antimicrobial potential might lead to an improved efficacy of advanced treatment of UTIs.</p></div>","PeriodicalId":396,"journal":{"name":"Nanomedicine: Nanotechnology, Biology and Medicine","volume":"50 ","pages":"Article 102685"},"PeriodicalIF":4.7000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine: Nanotechnology, Biology and Medicine","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549963423000369","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Urinary tract infections (UTIs) are among the most common bacterial infections. Despite a wide range of therapeutic options, treatment success is compromised by the efficient mechanism of tissue colonization of uropathogenic Escherichia coli. In advanced drug delivery systems, a similar, glycan-mediated targeting mechanism may be realized by conjugating the drug to a plant lectin, like wheat germ agglutinin (WGA).

We introduce a drug delivery vehicle consisting of human serum albumin as nanoparticle shell, olive oil as core component, the active pharmaceutical ingredients (API) trimethoprim and rifampicin as well as WGA to facilitate cellular internalization. When WGA was embedded into the proteinaceous particle shell, cell binding studies revealed up to 60 % higher cell binding potential. Additionally, nanoparticles showed a good efficacy against gram-negative just as against gram-positive bacteria.

The combination of the promising cell-associative properties and the proven antimicrobial potential might lead to an improved efficacy of advanced treatment of UTIs.

Abstract Image

人血清白蛋白纳米颗粒作为靶向递送抗生素以对抗细菌感染的多功能载体
尿路感染是最常见的细菌感染之一。尽管有广泛的治疗选择,但治疗成功受到尿路致病性大肠杆菌组织定植的有效机制的影响。在先进的药物传递系统中,类似的,聚糖介导的靶向机制可以通过将药物偶联到植物凝集素,如小麦胚芽凝集素(WGA)来实现。我们引入了一种以人血清白蛋白为纳米颗粒外壳,橄榄油为核心成分,活性药物成分(API)甲氧苄啶和利福平,以及WGA组成的药物传递载体,以促进细胞内化。当WGA被嵌入到蛋白颗粒壳中时,细胞结合研究显示细胞结合电位提高了60%。此外,纳米颗粒对革兰氏阴性菌和革兰氏阳性菌均表现出良好的效果。有希望的细胞结合特性和已证实的抗菌潜力的结合可能导致uti的高级治疗效果的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.10
自引率
3.60%
发文量
104
审稿时长
4.6 months
期刊介绍: Nanomedicine: Nanotechnology, Biology and Medicine (NBM) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信